Article Search
닫기

Microbiology and Biotechnology Letters

보문(Article)

View PDF

Food, Environment, and Other Topics in Biotechnology

Microbiol. Biotechnol. Lett. 2014; 42(4): 354-360

https://doi.org/10.4014/kjmb.1407.07009

Received: July 22, 2014; Accepted: September 20, 2014

토복령 추출물의 항비만 활성

The Anti-Obesity Effect of Smilax china Extract

Jung Ae Park 1, Kyong-Suk Jin 1, Hyun Ju Kwon 1, 2 and Byung Woo Kim 1, 2*

1Blue-Bio Industry Regional Innovation Center, Dong-Eui University, Busan 614-714, Republic of Korea, 2Department of Life Science and Biotechnology, College of Natural Science and Human Ecology, Dong-Eui University, Busan 614-714, Republic of Korea

In this study, the anti-obesity activity of Smilax china methanol extract (SCME) was evaluated using a pancreatic lipase enzyme inhibition assay, and a cell culture model system. Results indicated that, SCME effectively inhibited pancreatic lipase enzyme activity in a dose-dependent manner. Furthermore, SCME significantly suppressed insulin, dexamethasone, 3-isobutyl-1-methylxanthine- induced adipocyte differentiation, lipid accumulation, and triglyceride contents on 3T3-L1 preadipocytes, in a dosedependent manner. The anti-adipogenic effect was modulated by cytidine-cytidine-adenosine-adenosine-thymidine (CCAAT)/ enhancer binding proteins (C/EBP) α, C/EBPβ, and the peroxisome proliferator-activated receptor γ gene and protein expressions. Moreover, SCME triggered lipolysis effects dose-dependently on adipocyte. Taken together, these results provide an important new insight into SCME, indicating that it possesses anti-obesity activity through pancreatic lipase inhibition, anti-adipogenic and lipolysis effects. SCME may therefore be utilized as a promising source in the field of nutraceuticals. The identification of active compounds that confer the anti-obesity activities of SCME may be a logical next step.

Keywords: Smilax china methanol extract, anti-obesity activity, lipase inhibition activity, anti-adipogenic and lipolysis effects

  1. Attie AD, Scherer PE. 2009. Adipocyte metabolism and obesity. J. Lipid Res. 50: 395-399.
  2. Bae CR, Kwon DY, Cha YS. 2013. Anti-obesity effects of salted and unsalted doenjang supplementation in C57BL/6J mice fed with high fat diet. J. Korean Soc. Food Sci. Nutr. 42:1036-1042.
  3. Back SH, Kim SH, Son KH, Chung KC, Chang HW. 1994. Inactivation of human pleural fluod phospholipase A2 by dioscin. Arch. Pharm. Res. 17: 218-222.
  4. Cao Z, Umek RM, McKnight SL. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5: 1538-1552.
  5. Darlington GJ, Ross SE, MacDougald OA. 1998. The role of C/EBP genes in adipocyte differentiation. J. Biol. Chem. 273:30057-30060.
  6. Després JP, Lemieux I. 2006. Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
  7. Ferraro KF, Su YP, Gretebeck RJ, Black DR, Badylak SF. 2002. Body mass index and disability in adulthood: a 20-year panel study. Am. J. Public Health. 92: 834-840.
  8. Flier JS, Maratos Flier E. 1998. Obesity and the hypothalamus:novel peptides for new pathways. Cell 92: 437-440.
  9. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114:1752-1761.
  10. Grundy SM. 1998. Multifactorial causation of obesity: implications for prevention. Am. J. Clin. Nutr. 67: 563-572.
  11. Gupta R, Rathi P, Gupta N, Bradoo S. 2003. Lipase assays for conventional and molecular screening: an overview. Biotechnol. Appl. Biochem. 37: 63-71.
  12. Heck AM, Yanovski JA, Calis KA. 2000. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 20:270-279.
  13. Hotamisligil GS. 2006. Inflammation and metabolic disorders. Nature 444: 860-867.
  14. Kedare SB, Singh RP. 2011. Genesis and development of DPPH method of antioxidant assay. J. Food Sci. Technol. 48:412-422.
  15. Khan I, Nisar M, Ebad F, Nadeem S, Saeed M, Khan H, et al. 2009. Anti-inflammatory activities of sieboldogenin from Smilax china Linn.: experimental and computational studies. J. Ethnopharmacol. 121: 175-177.
  16. Kim SH, Kim JY, Ryu KA, Sohn CM. 2007. Evaluation of the dietary diversity and nutrient intakes in obese adults. Korean J. Community Nutr. 12: 583-591.
  17. Kim SW, Chung KC, Son KH, Kang SS. 1989. Steroidal saponins from the rhizomes of Smilax china. Korean J. Phamacogn. 20: 76-82.
  18. Kim SW, Son KH, Chung KC. 1989. Mutagenic effect of steroidal saponins from Smilax china rhizomes. Yakhak Hoeji 33:285-289.
  19. Kwon CS, Sohn HY, Kim SH, Kim JH, Son KH, Lee JS, et al. 2003. Anti-obesity effect of Dioscorea nipponica Makino with lipase-inhibitory activity in rodents. Biosci. Biotechnol. Biochem. 67: 1451-1456.
  20. Lee SE, Ju EM, Kim JH. 2001. Free radical scavenging and antioxidant enzyme fortifying activities of extracts from Smilax china root. Exp. Mol. Med. 33: 263-268.
  21. Li YL, Gan GP, Zhang HZ, Wu HZ, Li CL, Huang YP, et al. 2007. A flavonoid glycoside isolated from Smilax china L. rhizome in vitro anticancer effects on human cancer cell lines. J. Ethnopharmacol. 113: 115-124.
  22. Liu F, Kim J, Li Y, Liu X, Li J, Chen X. 2001. An extract of Lagerstroemia speciosa L. has insulin-like uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J. Nutr. 131: 2242-2247.
  23. Majdalawieh AF, Carr RI. 2010. In vitro investigation of the potential immunomodulatory and anti-cancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum). J. Med. Food. 13: 371-381.
  24. Mukherjee M. 2003. Human digestive and metabolic lipases a brief review. J. Mol Catal. B. Enzym. 22: 369-376.
  25. Ntambi JM, Kim YC. 2000. Adipocyte differentiation and gene expression. J. Nutr. 130: 3122-3126.
  26. Park JA, Park C, Han MH, Kim BW, Chung YH, Choi YH. 2011. Inhibition of adipocyte differentiation and adipogenesis by aged black garlic extracts in 3T3-L1 preadipocytes. J. Life Sci. 21: 720-728.
  27. Rosen ED, Hsu CH, Wang X, Sakai X, Freeman MW, Gonzalez FJ, et al. 2001. C/EBPα induces adipogenesis through PPAR: a unified pathway. Genes Dev. 16: 22-26.
  28. Wei Y, Xu Y, Han X, Qi Y, Xu L, Xu Y, et al. 2013. Anti-cancer effects of dioscin on three kinds of human lung cancer cell lines through inducing DNA damage and activating mitochondrial signal pathway. Food Chem. Toxicol. 59: 118-128.
  29. Xu W, Liu J, Li C, Wu HZ, Liu YW. 2008. Kaempferol-7-ObetaD-glucoside (KG) isolated from Smilax china L. rhizome induces G2/M phase arrest and apoptosis on HeLa cells in a p53-independent manner. Cancer Lett. 264: 229-240.

Starts of Metrics

Share this article on :

Related articles in MBL

Most Searched Keywords ?

What is Most Searched Keywords?

  • It is most registrated keyword in articles at this journal during for 2 years.